Short communicationDetermination of cholesteryl 14-methylhexadecanoate in blood serum by reversed-phase high-performance liquid chromatography

Add time:08/20/2019    Source:sciencedirect.com

A simple reversed-phase HPLC method has been developed for the determination of cholesteryl 14-methylhexadecanoate (CMH) in the blood serum. Lipids are extracted from 0.1 ml of blood serum and after centrifugation, the extract is chromatographed and individual cholesteryl esters, including CMH are separated and eluted with an acetonitrile—2-propanol mixture. The quantification of cholesteryl 14-methylhexadecanoate is precise and highly reproducible and the analysis may be completed within 35 min. The level of CMH in the blood of cancer patients appears to be a useful marker of malignant tumors.

We also recommend Trading Suppliers and Manufacturers of CHOLESTERYL ELAIDATE (cas 19485-76-8). Pls Click Website Link as below: cas 19485-76-8 suppliers

Prev:First catalytic hetero-Diels–Alder reaction of imidazole-2-thiones and in silico biological evaluation of the cycloadducts
Next:Ion-pair in-tube solid-phase microextraction and capillary liquid chromatography using a titania-based column: Application to the specific Lauralkonium chloride (cas 19486-61-4) determination in water☆)